When It Rains Gold, Put Out The Bucket: 2 Wonderful Income Bargains

The article highlights Bristol-Myers Squibb (BMY) and Rexford Industrial Realty (REXR) as undervalued, high-quality, dividend-paying stocks with temporary setbacks, offering attractive yields of 5.3% and 5% respectively. BMY benefits from a strong drug pipeline, while REXR capitalizes on supply constraints in Southern California's industrial market; both companies possess solid balance sheets and potential for substantial total returns through income and valuation recovery.

Analysis

The article highlights Bristol-Myers Squibb (BMY) and Rexford Industrial Realty (REXR) as undervalued, high-quality, dividend-paying stocks experiencing temporary setbacks, presenting opportunities for patient investors seeking both value and income. BMY is characterized as deeply undervalued, offering a significant 5.3% dividend yield, supported by strong profitability and a promising neurodegenerative drug pipeline. Rexford Industrial Realty provides a 5% yield and benefits from its strategic position in the supply-constrained Southern California industrial real estate markets, currently trading substantially below its historical valuation metrics. Both companies are noted for possessing strong balance sheets and competitive advantages, which underpin the potential for outsized total returns through a combination of dividend income and valuation recovery. The investment thesis focuses on identifying such fundamentally sound companies whose market prices do not currently reflect their intrinsic worth or future prospects.

Key Decisions for Investors

• Investors seeking income and potential capital appreciation may find BMY and REXR attractive due to their high dividend yields of 5.3% and 5% respectively, and current undervaluation.
• Consider the specific catalysts for each company: BMY's neurodegenerative drug pipeline developments and REXR's ability to capitalize on tight Southern California industrial market conditions are key to realizing their projected outsized returns.
• Given both stocks are presented as having 'temporary setbacks', investors should assess their own tolerance for potential volatility and the timeline for the anticipated valuation recovery, performing due diligence on the nature and expected duration of these setbacks.